ArticleEuropean journal of cancer (Oxford, England : 1990)2024

Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615).

Jennifer H Foster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.